Company facts
- Headquarters
- Las Vegas, Nevada
- Most recent report
- 8-K, filed Sep 1, 2026
- Incorporated
- Nevada
- Filings on record
- 179 filings
- On EDGAR
- CIK 1415397
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company
Financials 8 of 38
News 8 of 25
Prospectuses and Registrations 8 of 19
- 424B3 Prospectus supplement for an offering Nov 21, 2024
- S-1 Registration statement for an offering Sep 13, 2024
- POS AM Post-effective amendment to a registration Jun 1, 2023
- POS AM Post-effective amendment to a registration Jun 1, 2023
- POS AM Post-effective amendment to a registration May 4, 2023
- POS AM Post-effective amendment to a registration May 2, 2023
- S-1 Registration statement for an offering Jun 28, 2022
- POS AM Post-effective amendment to a registration May 26, 2022
Ownership 8 of 39
- 4 Insider reported a trade Apr 6, 2026
- 3 Insider reported their initial holding Sep 8, 2025
- 4 Insider reported a trade Mar 12, 2025
- 4 Insider reported a trade Mar 11, 2025
- 4 Insider reported a trade Mar 6, 2025
- 3 Insider reported their initial holding Feb 13, 2025
- 4 Insider reported a trade Mar 25, 2024
- 4 Insider reported a trade Mar 25, 2024
Other 8 of 58
- EFFECT Notice that a registration became effective Sep 26, 2024
- CORRESP Reply to SEC staff Sep 24, 2024
- UPLOAD Comment letter from SEC staff Sep 23, 2024
- DEF 14C Jun 4, 2024
- PRE 14C May 23, 2024
- EFFECT Notice that a registration became effective Jun 13, 2023
- EFFECT Notice that a registration became effective Jun 13, 2023
- EFFECT Notice that a registration became effective Jul 8, 2022
Everything here comes from Raphael Pharmaceutical Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.